• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

155
16
11
8
7

COUNTRY

7
6
4
2
1

CATEGORIES

  • 60
  • 40
  • 33
  • 24
  • 13
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

49
59
77
244

PUBLISHED

3
13
59
244

PRODUCT TYPE

200
42
1
1

Search "Pharmaceutical Manufacturers (Japan) - Portfolio Analysis" returned 244 results.

PRODUCT TITLE

Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players

GBI Research, the leading business intelligence provider, has released its latest research “Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign...

April 2013
FROM

Pharmaceutical Packaging Industry - 2011 Yearbook

GBI Research, the leading business intelligence provider, has released its latest research “Pharmaceutical Packaging Industry - 2011 Yearbook” which provides insights into the global pharmaceutical...

December 2011
FROM

The Future of the Pharmaceutical Packaging Industry - Emerging Economies Poised to Capitalize on Increasing Demand

“The Future of the Pharmaceutical Packaging Industry - Emerging Economies Poised to Capitalize on Increasing Demand” provides insights on the global pharmaceutical packaging market and gives information...

December 2009
FROM
The Outlook for Pharmaceuticals in the Middle East and North Africa The Outlook for Pharmaceuticals in the Middle East and North Africa - Product Thumbnail Image

The Outlook for Pharmaceuticals in the Middle East and North Africa

In spite of recent political unrest, economic, social and demographic changes are making the pharmaceutical markets in the Middle East & North Africa (MENA) region more attractive. The Economist Intelligence...

February 2012
FROM
The Top 50 European Manufacturers of Orthopaedic Implants The Top 50 European Manufacturers of Orthopaedic Implants - Product Thumbnail Image

The Top 50 European Manufacturers of Orthopaedic Implants

Did you know? - Approximately 8 out of 10 people experience severe low back pain at least once in their life - 40% of the population over 70 in the industrialised world suffer from osteoarthritis of...

January 2012
FROM
Taisho Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012 Taisho Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012 - Product Thumbnail Image

Taisho Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012

Taisho Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Taisho Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012” provides...

December 2012
FROM
Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report - Product Thumbnail Image

Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report

TechNavio's analysts have conducted a survey on Impact of Patent Expiration on Key Drugs Categories for 2012-2016. The survey assessed the Impact of Patent Expiration on several key drugs categories...

November 2012
FROM

Prefilled Syringes Market, 2013 - 2023

Prefilled syringes are gaining strong acceptance in the market as drug delivery systems for injectable drugs They have become a preferred device for parenteral administration of drugs, mainly used for...

July 2013
FROM
Global Over-the-counter Pharmaceutical Market 2012-2016 Global Over-the-counter Pharmaceutical Market 2012-2016 - Product Thumbnail Image

Global Over-the-counter Pharmaceutical Market 2012-2016

TechNavio's analysts forecast the Global Over-the-counter (OTC) Pharmaceutical market to grow at a CAGR of 1.9 percent over the period 2012-2016. One of the key factors contributing to this market growth...

January 2013
FROM

Daewoong Pharmaceutical Co., Ltd. (069620) - Financial and Strategic SWOT Analysis Review

Daewoong Pharmaceutical Co., Ltd. (069620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

May 2014
FROM

Global Fuel Cell Market by Technology, Application, Type, Geography, Fuel, Installation, Trends and Forecasts (2011 – 2016)

Global fuel cell market reached 0 14 million unit shipments in 2010 from mere 11 thousand units in 2007 During this period, shipments grew by CAGR of 132% and are further expected to rise by 115% CAGR...

May 2011
FROM
Hormone Replacement Therapy (HRT) - Global Strategic Business Report Hormone Replacement Therapy (HRT) - Global Strategic Business Report - Product Thumbnail Image

Hormone Replacement Therapy (HRT) - Global Strategic Business Report

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America,...

January 2014
FROM
Biosimilars - Global Strategic Business Report Biosimilars - Global Strategic Business Report - Product Thumbnail Image

Biosimilars - Global Strategic Business Report

This report analyzes the worldwide markets for Biosimilars in US$ Million The report provides separate comprehensive analytics for US, Europe, and Japan Annual estimates and forecasts are provided for...

April 2012
FROM

Manufacturing of Solid Dosage Forms - Transformation in Manufacturing Concepts and Expanding Contract Manufacturers' Production Capacity May Force Regulatory Bodies to Re-Design Guidelines on Quality Standards

GBI Research's report, “Manufacturing of Solid Dosage Forms - Transformation in Manufacturing Concepts and Expanding Contract Manufacturers' Production Capacity May Force Regulatory Bodies to Re-Design...

February 2011
FROM

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs Summary GBI Research, the leading business intelligence...

December 2012
FROM
The Top 50 Distributors Of Dental Surgery & Laboratory Products In Europe The Top 50 Distributors Of Dental Surgery & Laboratory Products In Europe - Product Thumbnail Image

The Top 50 Distributors Of Dental Surgery & Laboratory Products In Europe

According to the latest figures from the European Commission, the population of Europe was 740 0 million in 2012 It is estimated that there are 343,992 dentists, 155,994 dental technicians and 30,963...

March 2013
FROM

Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions

“Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs,Top Pharma Companies and Key Mergers and Acquisitions” provides key data, information and analysis of the...

December 2010
FROM
Competitor Analysis: Diabetes Drug Pipeline Competitor Analysis: Diabetes Drug Pipeline - Product Thumbnail Image

Competitor Analysis: Diabetes Drug Pipeline

This Competitive Intelligence report on the Diabetes Drug Pipeline, as of November 2008 provides a competitor analysis in the development pipeline of novel antidiabetic treatment modalities for type...

November 2008
FROM
Vitamins - Global Strategic Business Report Vitamins - Global Strategic Business Report - Product Thumbnail Image

Vitamins - Global Strategic Business Report

This report analyzes the worldwide markets for Vitamins in US$ Thousand by the following Product Segments: Vitamin A, Vitamin D, Vitamin E, Vitamin B Complex, Vitamin C, Vitamin D, Vitamin E, and Vitamin...

May 2013
FROM
The Top 25 U.S. Pharmaceutical Manufacturing Companies The Top 25 U.S. Pharmaceutical Manufacturing Companies - Product Thumbnail Image

The Top 25 U.S. Pharmaceutical Manufacturing Companies

Did you know? - Hospira, Inc is the world leader in specialty generic injectable pharmaceuticals - Johnson & Johnson’s broad portfolio focuses on unmet medical needs across several therapeutic areas:...

September 2011
FROM
Loading Indicator